The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn ...

The pharmaceutical giant has agreed to a $2.2bn (£1.68bn) settlement to resolve lawsuits in the US alleging that the ...

GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...

GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US. In a statement released after the close of ...

GSK said late Wednesday that it agreed to settle a vast majority of lawsuits concerning its discontinued heartburn medicine Zantac. "GSK Shares Climb on $2.2 Bln Zantac Lawsuit Settlement," at 0754 ...

GSK PLC will pay up to $2.2 billion to settle some 80,000 US lawsuits over its heartburn medication Zantac, generically known ...

GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court ...

FTSE 250-listed ventilation firm Volution has marked the tenth anniversary of its stock market listing with an 8.7% rise in ...

The predicted rise in forecourt prices comes as the amount paid by drivers for petrol has fallen by 15.5p since the start of ...

0544 ET – GSK’s $2.2 billion settlement to resolve the majority of Zantac litigation cases was welcomed by the market, with ...

GSK shares spike after the pharmaceutical giant agreed to pay as much as $2.2bn (£1.68bn) to settle lawsuits over Zantac ...